News Headlines Article

Report could boost effort targeting Part B drug costs
Modern Healthcare

More than half of the drugs Medicare beneficiaries receive in hospitals and physicians’ offices would be subject to price negotiations under proposed legislation, according to a GAO report. The Government Accountability Office reported this week that in 2010 Medicare spent $19.5 billion on Part B drugs, which are generally pharmaceuticals administered by physicians in their offices or hospital outpatient departments. And Medicare beneficiaries were the primary users of at least $11 billion worth of those drugs in 2010, the latest year for which data is available.